The polyphenol fisetin protects bone by repressing NF-κB and MKP-1-dependent signaling pathways in osteoclasts

Laurent Léotoing1, Fabien Wauquier, Jérôme Guicheux

  • 1Clermont Université, Université d'Auvergne, Clermont-Ferrand, France.

Plos One
|July 18, 2013
PubMed

Insights

The natural compound fisetin prevents bone loss in osteoporosis models by inhibiting osteoclast activity and regulating key signaling pathways. This polyphenol shows promise as a bone-protective agent, offering a potential alternative to current treatments.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoporosis leads to increased fracture risk and reduced quality of life.
  • Current osteoporosis treatments may have adverse side effects.
  • Plant-derived compounds offer a promising alternative for disease prevention and treatment.

Purpose of the Study:

  • To investigate the efficacy of the polyphenol fisetin in preventing osteoporosis.
  • To elucidate the cellular and molecular mechanisms underlying fisetin's bone-protective effects.

Main Methods:

  • In vivo studies using estrogen deficiency and inflammation-induced osteoporosis mouse models.
  • Assessment of bone mineral density, micro-architecture, and bone markers.
  • In vitro analysis of osteoclast differentiation, activity, and related signaling pathways (NF-κB, MAPK, c-Fos, NFATc1).
  • Investigation of fisetin's effect on MKP-1 (a phosphatase) and its interaction with signaling pathways.

Main Results:

  • Fisetin consumption significantly prevented bone loss and improved bone parameters in vivo.
  • Fisetin repressed RANKL-induced osteoclast differentiation and activity in vitro.
  • Fisetin negatively regulated key signaling pathways (NF-κB, p38 MAPK, JNK) and transcription factors (c-Fos, NFATc1).
  • Fisetin inhibited the proteasomal degradation of MKP-1, enhancing its bone-protective effects.

Conclusions:

  • Fisetin demonstrates significant bone-protective effects in osteoporosis models.
  • Fisetin acts by inhibiting osteoclastogenesis and modulating crucial cellular signaling pathways.
  • Fisetin's mechanism involves stabilizing MKP-1, suggesting its potential as a therapeutic agent for osteoporosis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...